Israeli - Kiingereza - Ministry of Health

salomon,levin & elstein ltd - fluorouracil - solution for injection - fluorouracil 50 mg/ml - fluorouracil - palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas, in selected patients considered incurable by surgery or other means.as leucovorin-fluorouracil chemotherapy combination for cancer treatment.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - fluorouracil 50 mg/ml - solution for injection - 50 mg/ml - active: fluorouracil 50 mg/ml excipient: nitrogen sodium hydroxide water for injection - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - fluorouracil, quantity: 5000 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.

Marekani - Kiingereza - NLM (National Library of Medicine)

sandoz inc - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil 50 mg in 1 ml - fluorouracil is effective in the palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas. fluorouracil therapy is contraindicated for patients in a poor nutritional state, those with depressed bone marrow function, those with potentially serious infections or those with a known hypersensitivity to fluorouracil.

Kenya - Kiingereza - Pharmacy and Poisons Board

pro med pharmaceuticals limited p.o.box 22953-00100 nairobi - flucloxacillin - tablet - flucloxacillin 500mg - flucloxacillin

Kenya - Kiingereza - Pharmacy and Poisons Board

pro med pharmaceuticals ltd box 22953 -00100 nairobi - flucloxacillin - tablet - flucloxacillin 250mg - flucloxacillin

Kenya - Kiingereza - Pharmacy and Poisons Board

crown healthcare crownplex mombasa road, opp jkia flyover - p.o. - flucloxacillin bp - capsule, hard - flucloxacillin 500mg - flucloxacillin

Kenya - Kiingereza - Pharmacy and Poisons Board

flucloxacillin sodium - powder and solvent for oral solution - flucloxacillin 125 mg - flucloxacillin

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - flucloxacillin sodium monohydrate, quantity: 281.89 mg - capsule - excipient ingredients: methyl hydroxybenzoate; titanium dioxide; indigo carmine; gelatin; magnesium stearate; propyl hydroxybenzoate; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - flucloxacillin sodium monohydrate, quantity: 563.78 mg - capsule - excipient ingredients: indigo carmine; methyl hydroxybenzoate; propyl hydroxybenzoate; gelatin; magnesium stearate; titanium dioxide; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.